Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpheart.00929.2008PMID 19202000PMCID PMC2670691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• VASCULAR DYSFUNCTION IN THE α‐GALACTOSIDASE A‐KNOCKOUT MOUSE IS AN ENDOTHELIAL CELL‐, PLASMA MEMBRANE‐BASED DEFECT

  2008cited by this paper
• Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.

  2008cited by this paper
• Caveolin-associated Accumulation of Globotriaosylceramide in the Vascular Endothelium of α-Galactosidase A Null Mice*

  2007cited by this paper
• Increased spontaneous tone in renal arteries of spontaneously hypertensive rats.

  2007cited by this paper
• Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment

  2007cited by this paper
• The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease

  2006cited by this paper
• Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A.

  2006cited by this paper
• COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice.

  2006cited by this paper
• COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice.

  2005cited by this paper
• Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

  2005cited by this paper
• &agr;-Galactosidase A Deficiency Accelerates Atherosclerosis in Mice With Apolipoprotein E Deficiency

  2005cited by this paper
• Endothelium‐dependent contractions in hypertension

  2005influential reference
• An in vitro model of Fabry disease.

  2005cited by this paper
• Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses

  2005cited by this paper
• Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease

  2005cited by this paper
• Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

  2005cited by this paper
• Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with α galactosidase A

  2005cited by this paper
• Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction.

  2005cited by this paper
• Endothelial cell dysfunction: can't live with it, how to live without it.

  2005cited by this paper
• Endothelium-Dependent Contractions Occur in the Aorta of Wild-Type and COX2−/− Knockout But Not COX1−/− Knockout Mice

  2005cited by this paper
• Type 2 Diabetic Mice Have Increased Arteriolar Tone and Blood Pressure: Enhanced Release of COX-2–Derived Constrictor Prostaglandins

  2005cited by this paper
• Enhanced Contractility of Renal Afferent Arterioles From Angiotensin-Infused Rabbits: Roles of Oxidative Stress, Thromboxane Prostanoid Receptors, and Endothelium

  2004cited by this paper
• Nitric oxide synthase-inhibition hypertension is associated with altered endothelial cyclooxygenase function.

  2004cited by this paper
• Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis.

  2003cited by this paper
• Src kinase mediates the regulation of phospholipase C-gamma activity by glycosphingolipids.

  2003cited by this paper
• Cyclooxygenase is regulated by ET-1 and MAPKs in peripheral lung microvascular smooth muscle cells.

  2003cited by this paper
• Src Kinase Mediates the Regulation of Phospholipase C-γ Activity by Glycosphingolipids*

  2003cited by this paper
• Regulation of phospholipase C-gamma activity by glycosphingolipids.

  2002cited by this paper
• Regulation of Phospholipase C-γ Activity by Glycosphingolipids*

  2002cited by this paper
• Cyclooxygenase isozyme expression and intimal hyperplasia in a rat model of balloon angioplasty.

  2002cited by this paper
• Enhanced Endothelium-Dependent Vasodilation in Fabry Disease

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries

  2001cited by this paper
• Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry Disease: Reversal by Enzyme Replacement Therapy

  2001cited by this paper
• Endothelial dysfunction induced by oxidized low-density lipoproteins in isolated mouse aorta: a comparison with apolipoprotein-E deficient mice.

  2001cited by this paper
• α-Galactosidase A deficiency. Fabry disease

  2001cited by this paper
• CYCLOOXYGENASE INHIBITION REDUCES BLOOD PRESSURE ELEVATION AND VASCULAR REACTIVITY DYSFUNCTION CAUSED BY INHIBITION OF NITRIC OXIDE SYNTHASE IN RATS

  2000cited by this paper
• Cyclo‐oxygenase‐1 and −2 contribution to endothelial dysfunction in ageing

  2000cited by this paper
• alpha-Galactosidase A deficient mice: a model of Fabry disease.

  1997cited by this paper
• Endothelium‐Derived Vasoactive Factors: II Endothelium‐Dependent Contraction

  1991cited by this paper
• Endothelium‐Derived Vasoactive Factors: I Endothelium‐Dependent Relaxation

  1991cited by this paper
• Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.

  1986cited by this paper

• Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic mice

  2023cites this paper
• Endothelial Cell Dysfunction and Hypoxia as Potential Mediators of Pain in Fabry Disease: A Human-Murine Translational Approach

  2023cites this paper
• Xanthine oxidase inhibition protects against Western diet-induced aortic stiffness and impaired vasorelaxation in female mice.

  2017cites this paper
• A Comparison of Genetic Diversity of COX-III Gene in Lowland Chickens and Tibetan Chickens

  2017cites this paper
• Pathomechanisms of renal Fabry disease

  2017cites this paper
• Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis

  2016cites this paper
• Doença de Fabry, revisão de uma doença olho-rim

  2015cites this paper
• Fabry’s disease: an example of cardiorenal syndrome type 5

  2015cites this paper
• Fabry's disease.

  2014cites this paper
• Effects of cPLA-2 on the Migration and Proliferation of Human Vascular Smooth Muscle Cells and the 2-D Migratory Patterns of Tropomyosin in Femoral and Abdominal Aorta Tissue

  2014cites this paper
• Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A).

  2013cites this paper
• Fibrosis: a key feature of Fabry disease with potential therapeutic implications

  2013cites this paper
• Neurological complications of Anderson-Fabry disease.

  2013cites this paper
• Gastroenterological complications of Anderson-Fabry disease.

  2013cites this paper
• Globotriaosylsphingosine Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease

  2012cites this paper
• Kidney histologic alterations in α-Galactosidase-deficient mice

  2011cites this paper
• [Update on the treatment of Fabry's disease: pathophysiological concepts].

  2010cites this paper
• Actualización en el tratamiento de la enfermedad de Fabry: conceptos fisiopatológicos

  2010cites this paper
• Biochemistry of Fabry Disease

  2010cites this paper
• Current world literature.

  2010cites this paper
• Fabry disease

  2010cites this paper
• Neointimal Hyperplasia and Vasoreactivity Are Controlled by Genetic Elements on Rat Chromosome 3

  2010cites this paper
• Vasculopathy in patients with Fabry disease: current controversies and research directions.

  2010cites this paper